LDR | |
01290nam a2200289 a 4500 |
001 |
|
008523200 |
003 |
|
MiAaHDL |
005 |
|
20130605000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
890512s1988 xxu b f000 0 eng d |
010 |
⊔ |
⊔ |
‡a 88602644
|
035 |
⊔ |
⊔ |
‡asdr-pst.a818821
|
035 |
⊔ |
⊔ |
‡a(OCoLC)18425862
|
035 |
⊔ |
⊔ |
‡aLIAS1414057
|
040 |
⊔ |
⊔ |
‡cPSt
‡dWaOLN
|
050 |
0 |
⊔ |
‡aKF27
‡b.S675 1988b
|
074 |
⊔ |
⊔ |
‡a1031-A, 1031-B (microfiche)
|
086 |
0 |
⊔ |
‡aY 4.Sm 1:100-50
|
110 |
1 |
⊔ |
‡aUnited States.
‡bCongress.
‡bHouse.
‡bCommittee on Small Business.
‡bSubcommittee on Regulation and Business Opportunities.
|
245 |
1 |
0 |
‡aImpact of clandestine drug laboratories on small business :
‡bhearing before the Subcommittee on Regulation and Business Opportunities of the Committee on Small Business, House of Representatives, One Hundredth Congress, second session, Eugene, OR, May 13, 1988.
|
260 |
⊔ |
⊔ |
‡aWashington :
‡bU.S. G.P.O. :
‡bFor sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O.,
‡c1988.
|
300 |
⊔ |
⊔ |
‡aiii, 95 p. ;
‡c24 cm.
|
500 |
⊔ |
⊔ |
‡a"Serial no. 100-50."
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographical references.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aDrug control
‡zOregon.
|
650 |
⊔ |
0 |
‡aSmall business
‡zOregon.
|
650 |
⊔ |
0 |
‡aHazardous substances
‡zOregon.
|
650 |
⊔ |
0 |
‡aChemical laboratories
‡xEnvironmental aspects
‡zOregon.
|
650 |
⊔ |
0 |
‡aMethamphetamine
‡zOregon.
|
CID |
⊔ |
⊔ |
‡a008523200
|
DAT |
0 |
⊔ |
‡b20130605000000.0
|
DAT |
1 |
⊔ |
‡a20130709225806.0
‡b2023-12-16T19:20:03Z
|
DAT |
2 |
⊔ |
‡a2023-12-16T18:30:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-PST
‡dUNKNOWN
‡lloader.pl-002-002
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-pst.a818821
‡apst
‡bSDR
‡cPST
‡ppst.000014301391
‡sPST
‡z4.Sm 1:100-50
‡1a818821
|
974 |
⊔ |
⊔ |
‡bPST
‡cPST
‡d20231216
‡sgoogle
‡upst.000014301391
‡z4.Sm 1:100-50
‡y1988
‡rpd
‡qbib
‡tUS fed doc
|